tiprankstipranks
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement
PremiumThe Fly60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement
5M ago
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements
Premium
The Fly
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements
5M ago
60 Degrees granted University of Kentucky right to reference NDA for ARAKODA
Premium
The Fly
60 Degrees granted University of Kentucky right to reference NDA for ARAKODA
5M ago
60 Degrees Pharmaceuticals files $15M mixed securities shelf
PremiumThe Fly60 Degrees Pharmaceuticals files $15M mixed securities shelf
6M ago
60 Degrees Pharmaceuticals’ study of tafenoquine in babesiosis approved
Premium
The Fly
60 Degrees Pharmaceuticals’ study of tafenoquine in babesiosis approved
6M ago
60 Degrees announces first patient enrolled in clinical trial of Tafenoquine
Premium
The Fly
60 Degrees announces first patient enrolled in clinical trial of Tafenoquine
7M ago
60 Degrees Pharmaceuticals outlines upcoming trial of Tafenoquine
PremiumThe Fly60 Degrees Pharmaceuticals outlines upcoming trial of Tafenoquine
9M ago
60 Degrees receives FDA comments on Tafenoquine-Babesiosis trial protocol
Premium
The Fly
60 Degrees receives FDA comments on Tafenoquine-Babesiosis trial protocol
9M ago
60 Degrees price target raised to $1.30 from $1.20 at Ascendiant
Premium
The Fly
60 Degrees price target raised to $1.30 from $1.20 at Ascendiant
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100